# A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

> **NCT06154837** · PHASE1 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 130 (estimated)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK3862995B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06154837
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-27
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06154837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06154837, "A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06154837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*